FDA Releases Draft Guidance on the Labeling of Plant-Based Foods
The U.S. Food and Drug Administration (FDA) recently published draft guidance on the Labeling of Plant-Based Alternatives to Animal-Derived Foods (Draft Guidance). The Draft Guidance recommends best practices for naming plant-based alternatives to eggs, seafood, poultry, meat, and dairy products (with the exception of plant-based milk alternatives, which are addressed in a separate FDA draft guidance). FDA’s primary recommendation is that the statement of identity for plant-based alternatives should identify the specific plant source(s) of the food and should not suggest that animal source(s) are present or have been used as ingredients.
Plant-based alternative foods do not have established standards of identity. Therefore, in FDA parlance, plant-based alternative foods are “non-standardized foods.” Such foods must bear the common or usual name of the food. If no such name exists, the food must bear an accurate description of the food or a fanciful name commonly used by the public.
FDA recommends that manufacturers apply the labeling principles codified at 21 CFR § 102.5(a) when naming plant-based alternative foods. More specifically, the food should be labeled using an appropriately descriptive name that: (1) accurately identifies or describes the basic nature of the food or its characterizing properties or ingredients; (2) is uniform among identical or similar products; (3) is not confusingly similar to the name; and (4) distinguishes it from other dissimilar foods.
FDA recommends highlighting the specific plant source(s) from which the food is derived (e.g., “soy-based cheddar cheese,” “chickpea and lentil-based fish sticks,” “chia and flax seed egg-less scramble”). Even in cases where the label clearly states “plant-based,” FDA recommends additionally identifying the specific plant source(s) present in the product in an effort to provide consumers with sufficient details to inform their purchasing decisions (e.g., “Plant-Based Chickpea & Lentil-Based Fish Sticks”).
Below, we review additional (nonexhaustive) recommendations highlighted in the Draft Guidance:
FDA is accepting comments through May 7, 2025. If you have any questions concerning the Draft Guidance, please contact members of Perkins Coie’s Food & Beverage team.
The information provided is not intended to be a comprehensive review of all developments in the law and practice, or to cover all aspects of those referred to.
Readers should take legal advice before applying it to specific issues or transactions.
Editorial Disclaimer
Originally published before the Ashurst Perkins Coie combination. See disclaimer.